Express Scripts expands efforts in distribution of big-money gene therapies

Express Scripts, the largest pharmacy benefits management company in the United States with annual revenue of $100 billion, looks like it’s trying to diversify its business offerings. In an interview with Reuters, Steve Miller, chief medical officer of Express Scripts, confirmed the organization is in negotiations with biotechnology companies to exclusively distribute hemophilia therapies.